Literature DB >> 7590445

A possible role for antibodies to tumour necrosis factor alpha and to endotoxin in the treatment of Reye's syndrome.

M Odeh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7590445      PMCID： PMC1382830          DOI： 10.1136/gut.37.3.441

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  34 in total

Review 1.  Monoclonal anti-endotoxin antibodies for the treatment of gram-negative bacteremia and septic shock.

Authors:  J D Baumgartner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

2.  Roles of interleukin-1 and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia.

Authors:  S N Vogel; B E Henricson; R Neta
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

Review 3.  Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities.

Authors:  C Grunfeld; M A Palladino
Journal:  Adv Intern Med       Date:  1990

Review 4.  Cachectin/tumour necrosis factor.

Authors:  K J Tracey; H Vlassara; A Cerami
Journal:  Lancet       Date:  1989-05-20       Impact factor: 79.321

5.  Initial evaluation of human monoclonal anti-lipid A antibody (HA-1A) in patients with sepsis syndrome.

Authors:  C J Fisher; J Zimmerman; M B Khazaeli; T E Albertson; R P Dellinger; E A Panacek; G E Foulke; C Dating; C R Smith; A F LoBuglio
Journal:  Crit Care Med       Date:  1990-12       Impact factor: 7.598

Review 6.  Role of monoclonal antibody therapy in the treatment of infectious disease.

Authors:  H Chmel
Journal:  Am J Hosp Pharm       Date:  1990-11

7.  Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep.

Authors:  J Johnson; B Meyrick; G Jesmok; K L Brigham
Journal:  J Appl Physiol (1985)       Date:  1989-03

8.  Ca2+ responses to interleukin 1 and tumor necrosis factor in cultured human skin fibroblasts. Possible implications for Reye syndrome.

Authors:  B E Corkey; J F Geschwind; J T Deeney; D E Hale; S D Douglas; L Kilpatrick
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

9.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

Authors:  E J Ziegler; C J Fisher; C L Sprung; R C Straube; J C Sadoff; G E Foulke; C H Wortel; M P Fink; R P Dellinger; N N Teng
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

10.  Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock.

Authors:  A T Silva; K F Bayston; J Cohen
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.